Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
复制标题
DOI:
10.1038/3242
复制
发表时间:
1998-11-01
期刊:
影响因子:
82.9
通讯作者:
Smith, KD
中科院分区:
文献类型:
--
作者:
Kemp, S;Wei, HM;Smith, KD
As more functional redundancy in mammalian cells is discovered, enhanced expression of genes involved in alternative pathways may become an effective form of gene therapy. X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired very-long-chain fatty acid metabolism. The X-ALD gene encodes a peroxisomal membrane protein (ALDP) that is part of a small family of related peroxisomal membrane proteins. We show that 4-phenylbutyrate treatment of cells from both X-ALD patients and X-ALD knockout mice results in decreased levels of and increased beta-oxidation of very-long-chain fatty acids; increased expression of the peroxisomal protein ALDRP; and induction of peroxisome proliferation. We also demonstrate that ALDP and ALDRP are functionally related, by ALDRP cDNA complementation of X-ALD fibroblasts. Finally, we demonstrate the in vivo efficacy of dietary 4-phenylbutyrate treatment through its production of a substantial reduction of very-long-chain fatty acid levels in the brain and adrenal glands of X-ALD mice.